These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1393266)

  • 1. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo.
    Warren JB; Larkin SW; Coughlan M; Kajekar R; Williams TJ
    Br J Pharmacol; 1992 Jun; 106(2):331-4. PubMed ID: 1393266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
    Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin.
    Hughes SR; Brain SD
    Br J Pharmacol; 1991 Nov; 104(3):738-42. PubMed ID: 1797334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the mechanism of capsaicin-induced oedema in rabbit skin.
    Newbold P; Brain SD
    Br J Pharmacol; 1995 Feb; 114(3):570-7. PubMed ID: 7537589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.
    Chik CL; Inukai T; Ogiwara T; Boyd H; Li B; Karpinski E; Ho AK
    J Neurochem; 1996 Sep; 67(3):1005-13. PubMed ID: 8752106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant.
    Warren JB; Donnelly LE; Cullen S; Robertson BE; Ghatei MA; Bloom SR; MacDermot J
    Eur J Pharmacol; 1991 May; 197(2-3):131-4. PubMed ID: 1915565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE; Tatsuno I; Miyata A; Arimura A
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs.
    Naruse S; Suzuki T; Ozaki T; Nokihara K
    Peptides; 1993; 14(3):505-10. PubMed ID: 8101368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.
    Williams TJ
    Br J Pharmacol; 1982 Nov; 77(3):505-9. PubMed ID: 6958342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
    Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
    Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenylate cyclase-mediated vascular responses of rabbit aorta, mesenteric artery and skin microcirculation.
    Wilson AJ; Warren JB
    Br J Pharmacol; 1993 Oct; 110(2):633-8. PubMed ID: 7902177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
    Bodart V; Babinski K; Ong H; De Léan A
    Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons.
    Tatsuno I; Yada T; Vigh S; Hidaka H; Arimura A
    Endocrinology; 1992 Jul; 131(1):73-81. PubMed ID: 1319331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
    Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
    Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve.
    Escott KJ; Brain SD
    Br J Pharmacol; 1993 Oct; 110(2):772-6. PubMed ID: 8242250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation.
    Buckley TL; Brain SD; Rampart M; Williams TJ
    Br J Pharmacol; 1991 Jun; 103(2):1515-9. PubMed ID: 1884106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.